NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for AWRE yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Reduce operating expenses by $4 million annually starting Q2 2026 | Aware aims to cut $4 million in yearly costs starting Q2 2026. | Intact | operating expenses do not fall by $4 million annually next year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth business with weak recent financial performance and fragile earnings quality. The long-term thesis is in a watch state: momentum improved, but execution is still mixed and the business remains high risk.
AWRE is described as cheap versus peers, while the valuation model has low confidence and the expectations gap is negative. The current pricing is considered justified by weak execution, rather than by a broader combination of high valuation and turbulent conditions.
In the near term, recurring revenue growth and lower third-quarter operating expenses show some progress, but total revenue declined and nine-month operating expenses rose. Management’s platform, cost-reduction, and revenue-consistency priorities have mixed delivery, so the multi-year fundamentals depend on turning those efforts into steadier overall revenue.
A guidance cut on the next call would be a meaningful negative, especially given weak recent performance relative to the industry cohort. Lower interest rates or stabilization among major technology peers could support the sector backdrop, but the central swing factor remains AWRE’s ability to improve revenue consistency while sustaining cost reductions.
Over the next 1 to 3 years, AWRE’s long-term thesis rests on whether recurring revenue and expense discipline can lead to more consistent business performance. Progress is visible, but the evidence remains mixed and risk is high. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Aware Inc/MA's published investment case. The stated target is engage in material definitive agreements. |
| Intact |
| no material definitive agreements completed within next year |
Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve about 9% revenue growth in next year | Analysts expect about 9% revenue growth next year. | Broken | revenue growth falls below 9% in FY26 | Revenue growth: -13.88% FY2026-Q3; GAAP. Published target: >=9% YoY revenue growth. Annual target cannot be compared with a quarterly or TTM observation. Oct 30, 2026-13.881848 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.